Inhibition of Ube2d3 Expression Attenuates Radiosensitivity of Mcf-7 Human Breast Cancer Cells by Increasing Htert Expression and Activity

Wenbo Wang,Lei Yang,Liu Hu,Fen Li,Li Ren,Haijun Yu,Yu Liu,Ling Xia,Han Lei,Zhengkai Liao,Fuxiang Zhou,Conghua Xie,Yunfeng Zhou
DOI: https://doi.org/10.1371/journal.pone.0064660
IF: 3.7
2013-01-01
PLoS ONE
Abstract:The known functions of telomerase in tumor cells include replenishing telomeric DNA and maintaining cell immortality. We have previously shown the existence of a negative correlation between human telomerase reverse transcriptase (hTERT) and radiosensitivity in tumor cells. Here we set out to elucidate the molecular mechanisms underlying regulation by telomerase of radiosensitivity in MCF-7 cells. Toward this aim, yeast two-hybrid (Y2H) screening of a human laryngeal squamous cell carcinoma radioresistant (Hep2R) cDNA library was first performed to search for potential hTERT interacting proteins. We identified ubiquitin-conjugating enzyme E2D3 (UBE2D3) as a principle hTERT-interacting protein and validated this association biochemically. ShRNA-mediated inhibition of UBE2D3 expression attenuated MCF-7 radiosensitivity, and induced the accumulation of hTERT and cyclin D1 in these cells. Moreover, down-regulation of UBE2D3 increased hTERT activity and cell proliferation, accelerating G1 to S phase transition in MCF-7 cells. Collectively these findings suggest that UBE2D3 participates in the process of hTERT-mediated radiosensitivity in human breast cancer MCF-7 cells by regulating hTERT and cyclin D1.
What problem does this paper attempt to address?